STAINES-UPON-THAMES, United Kingdom, Sept. 3, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today reported the co

VANCOUVER and SAN DIEGO, CA, Sept. 3, 2019 /PRNewswire/ - Phivida Holdings Inc. (CSE: VIDA OTCQX: PHVAF) ("Phivida" or the "Company") is pleased to announce that Bloomgroove.com, its e-commerce site offering a full range of cannabis accessories, is now available to customers across North America. Bloomgroove.com is a custom-built platform that is fast and user-

CALGARY, Sept. 3, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (CSE:WLLW) is pleased to announce it has engaged The Howard Group as its capital markets communications advisor to assist with both traditional and online initiatives targeting institutional and retail investing groups as well as the larger investment community.

DALLAS, Sept. 3, 2019 /PRNewswire/ -- On September 1, Texas Gov. Greg Abbott signed into law a bill that eliminates the requirement for patients to obtain a doctor's prescription prior to seeking treatment from a licensed physical therapist. As a result,

WASHINGTON, Sept. 3, 2019 /PRNewswire/ -- America's Physician Groups (APG), the leading association in the country representing physician organizations practicing capitated, coordinated care, today announced the results of its 2019 Standards of Excellence™ (SOE®) member survey. Now in its 13th year, physician groups earn their survey rankings based on their per

WASHINGTON, Sept. 3, 2019 /PRNewswire/ -- Sixteen organizations representing health, environmental, farmer, and farmworker communities joined together today to call on EPA to remove glyphosate from the marketplace. The groups cite a combination of high-profile lawsuits, environmental impacts, increasing reports of weed resistance, and growing public concern over the

NYSE: ACB | TSX: ACB  EDMONTON, Sept. 3, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), today announced that it has scheduled its conference call to discuss the results for its fourth quarter and fiscal year ended June 30, 2019 on Thursday, September 12

NEWARK, Calif., Sept. 3, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the H.C. Wainwright & Co. 2019 Annual Healthcare Conference in New York. Prese

BOSTON, Sept. 3, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of

FRISCO, Texas, Sept. 3, 2019 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS) ("Addus" or the "Company"), a provider of comprehensive home care services, today announced that it has commenced a proposed public offering of 2,000,000 shares of its common stock. In addition, funds affiliated with Eos Partners (the "Selling Stockholders") intend to